In response to the ongoing Ebola outbreak affecting the Democratic Republic of Congo (DRC), the World Health Organization (WHO) has revealed plans to initiate trials for two vaccines targeting the Bundibugyo strain. These trials are scheduled to commence next week in the region where the outbreak is most severe.
The introduction of these vaccines aims to enhance the fight against the deadly virus, which has presented significant health challenges in the DRC.